Company Summary
Search
Home Page
 
Quest PharmaTech Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
January 31TradingN
Board of Directors
NamePosition
Eric Shi  Director of the Board
Ian McConnan  Director of the Board
Lorne T. Meikle  Chairman & Director
Madi Ragupathy Madiyalakan  Director of the Board
Not Applicable (None)  President
Shawn Lu  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
16/Dec/1996  Canada Alberta ALBERTA - 12/16/96 
Exchange Filing Office
Location
Calgary Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Research and Development of Pharmaceutical Products  Research and Development of Pharmaceutical Products and Sales of Cosmetics Products 
Securities
SymbolSecurity NameMarketStatus
QPTQuest Pharmatech Inc.TSX VentureTRADING
Name HistoryFromTo
Quest PharmaTech Inc.5/Oct/2005Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR 28/Apr/2015
Associations
Auditing Firm:  Ernst & Young, Chartered Accountants
Law Firm:  Miller Thomson LLP
Subsidiary:  Altachem Pharma Inc.
  Steroidogenesis Inhibitors Canada Inc.
  Danamedix Inc.
  Sonolight Pharmaceuticals Corp.
Transfer Agent:  Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  1/Dec/2015  NEWS RELEASE - QUEST PHARMATECH ANNOUNCES RESULTS FROM ITS 2015 AGM[CANADA NEWSWIRE]
    NEWS RELEASE - QUEST PHARMATECH'S SUBSIDIARY ONCOQUEST CLOSES U.S. $13 000 000 PREFERRED SHARE PRIVATE PLACEMENT WITH HEPALINK USA TO FUND IMMUNOTHERAPY FOR TREATMENT OF CANCER[CANADA NEWSWIRE]
    NEWS RELEASE - QUEST PHARMATECH CLOSES $2 000 000 PRIVATE PLACEMENT WITH HEPALINK USA[CANADA NEWSWIRE]
Bulletins  6/Nov/2015  PP-N-B
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data